Jennifer L Good Trevi Therapeutics, Inc. (TRVI) insider trading activity

Jennifer L Good is President & CEO of Trevi Therapeutics, Inc.. Currently has a direct ownership of 213,313 shares of TRVI, which is worth approximately $644,205. The most recent transaction as insider was on Sep 09, 2024, when has been sold 1,840 shares (Common Stock) at a price of $3.04 per share, resulting in proceeds of $5,593. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 213K

0% 3M change

n/a 12M change

Total Value Held $644,205

JENNIFER L GOOD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 09 2024	SELL Open market or private sale	$5,593 $3.04 p/Share	1,840 Reduced 0.86%	213,313 Common Stock
Sep 09 2024	BUY Exercise of conversion of derivative security	$2,631 $1.43 p/Share	1,840 Added 0.85%	215,153 Common Stock
Sep 06 2024	SELL Open market or private sale	$12,783 $3.03 p/Share	4,219 Reduced 1.94%	213,313 Common Stock
Sep 06 2024	BUY Exercise of conversion of derivative security	$6,033 $1.43 p/Share	4,219 Added 1.9%	217,532 Common Stock
Sep 05 2024	SELL Open market or private sale	$125,261 $3.11 p/Share	40,277 Reduced 15.88%	213,313 Common Stock
Sep 05 2024	BUY Exercise of conversion of derivative security	$57,596 $1.43 p/Share	40,277 Added 13.71%	253,590 Common Stock
Sep 04 2024	SELL Open market or private sale	$33,162 $3.02 p/Share	10,981 Reduced 4.9%	213,313 Common Stock
Sep 04 2024	BUY Exercise of conversion of derivative security	$15,702 $1.43 p/Share	10,981 Added 4.67%	224,294 Common Stock
Sep 03 2024	SELL Open market or private sale	$11,666 $3.02 p/Share	3,863 Reduced 1.78%	213,313 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$5,524 $1.43 p/Share	3,863 Added 1.75%	217,176 Common Stock
May 20 2024	SELL Open market or private sale	$71,605 $2.86 p/Share	25,037 Reduced 10.5%	213,313 Common Stock
May 20 2024	BUY Exercise of conversion of derivative security	$54,831 $2.19 p/Share	25,037 Added 9.51%	238,350 Common Stock
May 10 2024	SELL Open market or private sale	$13,276 $2.9 p/Share	4,578 Reduced 2.1%	213,313 Common Stock
May 10 2024	BUY Exercise of conversion of derivative security	$10,025 $2.19 p/Share	4,578 Added 2.06%	217,891 Common Stock

Also insider at

RYTM

RHYTHM PHARMACEUTICALS, INC. Healthcare

Director

JLG

Jennifer L Good

President & CEO

New Haven, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRVI shares.

Notify only if

Value

Insider Trading

Get notified when an Trevi Therapeutics, Inc. insider buys or sells TRVI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Trevi Therapeutics, Inc.

Track Activities on TRVI

Account